Variant report

Variant	nsv960440
Chromosome Location	chr17:20799926-20803206
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:45)
CpG islands
(count:61)
Chromatin interactive
region (count:0)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:45 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr17:20801602-20801919	K562	blood:	n/a	n/a
2	CEBPB	chr17:20803139-20803424	K562	blood:	n/a	chr17:20803347-20803355
3	CHD2	chr17:20803086-20803442	K562	blood:	n/a	n/a
4	CHD2	chr17:20802299-20802335	H1-hESC	embryonic stem cell:	n/a	n/a
5	CTCF	chr17:20799208-20799935	A549	lung:	n/a	chr17:20799603-20799621
6	CTCF	chr17:20799354-20799949	K562	blood:	n/a	chr17:20799603-20799621
7	PBX3	chr17:20801143-20801303	GM12878	blood:	n/a	n/a
8	POLR2A	chr17:20802738-20803515	K562	blood:	n/a	n/a
9	POLR2A	chr17:20801232-20801317	HepG2	liver:	n/a	n/a
10	POLR2A	chr17:20802231-20802352	H1-hESC	embryonic stem cell:	n/a	n/a
11	POLR2A	chr17:20799288-20799983	H1-hESC	embryonic stem cell:	n/a	n/a
12	POLR2A	chr17:20803181-20803457	H1-hESC	embryonic stem cell:	n/a	n/a
13	POLR2A	chr17:20802667-20802720	HepG2	liver:	n/a	n/a
14	POLR2A	chr17:20799911-20800131	K562	blood:	n/a	n/a
15	POLR2A	chr17:20802922-20803085	H1-hESC	embryonic stem cell:	n/a	n/a
16	POLR2A	chr17:20801078-20801444	H1-hESC	embryonic stem cell:	n/a	n/a
17	POLR2A	chr17:20800767-20801103	H1-hESC	embryonic stem cell:	n/a	n/a
18	POLR2A	chr17:20801695-20802127	H1-hESC	embryonic stem cell:	n/a	n/a
19	POLR2A	chr17:20802943-20804305	K562	blood:	n/a	n/a
20	POLR2A	chr17:20801120-20801448	H1-hESC	embryonic stem cell:	n/a	n/a
21	POLR2A	chr17:20802595-20802890	K562	blood:	n/a	n/a
22	POLR2A	chr17:20800938-20801513	H1-hESC	embryonic stem cell:	n/a	n/a
23	POLR2A	chr17:20802413-20802866	H1-hESC	embryonic stem cell:	n/a	n/a
24	POLR2A	chr17:20801605-20801882	K562	blood:	n/a	n/a
25	POLR2A	chr17:20801169-20801467	K562	blood:	n/a	n/a
26	POLR2A	chr17:20801808-20802103	H1-hESC	embryonic stem cell:	n/a	n/a
27	POLR2A	chr17:20802879-20803428	HepG2	liver:	n/a	n/a
28	POLR2A	chr17:20801917-20801954	Gliobla	brain:	n/a	n/a
29	POLR2A	chr17:20800695-20800870	H1-hESC	embryonic stem cell:	n/a	n/a
30	POLR2A	chr17:20802476-20802707	H1-hESC	embryonic stem cell:	n/a	n/a
31	POLR2A	chr17:20801663-20802257	H1-hESC	embryonic stem cell:	n/a	n/a
32	POLR2A	chr17:20802309-20802486	K562	blood:	n/a	n/a
33	POLR2A	chr17:20800500-20800932	H1-hESC	embryonic stem cell:	n/a	n/a
34	POLR2A	chr17:20803158-20803736	K562	blood:	n/a	n/a
35	POLR2A	chr17:20802456-20802473	H1-hESC	embryonic stem cell:	n/a	n/a
36	POLR2A	chr17:20801751-20802227	H1-hESC	embryonic stem cell:	n/a	n/a
37	POLR2A	chr17:20801121-20801455	K562	blood:	n/a	n/a
38	POLR2A	chr17:20802408-20802869	H1-hESC	embryonic stem cell:	n/a	n/a
39	POLR2A	chr17:20798809-20800181	H1-hESC	embryonic stem cell:	n/a	n/a
40	POLR2A	chr17:20802531-20802868	K562	blood:	n/a	n/a
41	POLR2A	chr17:20801770-20802152	H1-hESC	embryonic stem cell:	n/a	n/a
42	POLR2A	chr17:20799930-20799980	K562	blood:	n/a	n/a
43	TAL1	chr17:20801979-20801994	K562	blood:	n/a	n/a
44	TEAD4	chr17:20802016-20802355	H1-hESC	embryonic stem cell:	n/a	n/a
45	TEAD4	chr17:20801921-20802403	H1-hESC	embryonic stem cell:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr17:20800556-20800606	AG04450	lung:	fetal
2	chr17:20800556-20800606	H1-hESC	embryonic stem cell:	embryo
3	chr17:20800556-20800606	HCM	heart:	n/a
4	chr17:20800556-20800606	MCF-7	breast:	n/a
5	chr17:20800556-20800606	BE2_C	brain:	n/a
6	chr17:20800556-20800606	A549	lung:	n/a
7	chr17:20800556-20800606	NH-A	brain:	n/a
8	chr17:20800556-20800606	Caco-2	colon:	n/a
9	chr17:20800556-20800606	GM12892	blood:	n/a
10	chr17:20800556-20800606	RPTEC	kidney:	n/a
11	chr17:20800556-20800606	HEK293	kidney:	embryo
12	chr17:20800556-20800606	PFSK-1	brain:	n/a
13	chr17:20800556-20800606	HPAEpiC	pulmonary alveolar:	n/a
14	chr17:20800556-20800606	K562	blood:	n/a
15	chr17:20800556-20800606	NB4	blood:	n/a
16	chr17:20800556-20800606	GM19239	blood:	n/a
17	chr17:20800556-20800606	HepG2	liver:	n/a
18	chr17:20800556-20800606	HCF	heart:	n/a
19	chr17:20800556-20800606	CMK	blood:	n/a
20	chr17:20800556-20800606	NHBE	bronchial:	n/a
21	chr17:20800556-20800606	HIPEpiC	eye:	n/a
22	chr17:20800556-20800606	HCT-116	colon:	n/a
23	chr17:20800556-20800606	SK-N-MC	brain:	n/a
24	chr17:20800556-20800606	Jurkat	blood:	n/a
25	chr17:20800556-20800606	ECC-1	luminal epithelium:	n/a
26	chr17:20800556-20800606	HEEpiC	esophagus:	n/a
27	chr17:20800556-20800606	NT2-D1	testis:	n/a
28	chr17:20800556-20800606	HMEC	breast:	n/a
29	chr17:20800556-20800606	MCF10A-Er-Src	breast:	n/a
30	chr17:20800556-20800606	IMR90	lung:	fetal
31	chr17:20800556-20800606	AG09319	gingival:	n/a
32	chr17:20800556-20800606	HRPEpiC	eye:	n/a
33	chr17:20800556-20800606	HAEpiC	amniotic membrane:	n/a
34	chr17:20800556-20800606	GM06990	blood:	n/a
35	chr17:20800556-20800606	GM12878	blood:	n/a
36	chr17:20800556-20800606	SK-N-SH_RA	brain:	n/a
37	chr17:20800556-20800606	BJ	skin:	n/a
38	chr17:20800556-20800606	NHDF-neo	bronchial:	n/a
39	chr17:20800556-20800606	ProgFib	skin:	n/a
40	chr17:20800556-20800606	Hepatocyte	liver:	n/a
41	chr17:20800556-20800606	HCPEpiC	choroid plexus:	n/a
42	chr17:20800556-20800606	SKMC	muscle:	n/a
43	chr17:20800556-20800606	HRE	kidney:	n/a
44	chr17:20800556-20800606	AG10803	skin:	n/a
45	chr17:20800556-20800606	HL-60	blood:	n/a
46	chr17:20800556-20800606	LNCaP	prostate:	n/a
47	chr17:20800556-20800606	AG09309	skin:	n/a
48	chr17:20800556-20800606	PANC-1	pancreas:	n/a
49	chr17:20800556-20800606	SK-N-SH	brain:	n/a
50	chr17:20800556-20800606	SAEC	small airway:	n/a

No data

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-DHRS7B-5	chr17:20802293-20802444	ENSG00000233098.3

No data

Variant related genes	Relation type
CCDC144NL	TF binding region
RNU6-1178P	TF binding region
CCDC144NL	CpG island
RNU6-1178P	CpG island

Extended variants
information (count: 283 )
Associated
traits (count: 151 )

Variant overlapped rSNPs/rCNVs (count:283 , 50 per page) page: 1 2 3 4 5 6

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs112409982	chr17:20799941-20799942	Weak transcription Strong transcription Genic enhancers Enhancers Active TSS Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
2	rs533240022	chr17:20799943-20799944	Weak transcription Strong transcription Genic enhancers Enhancers Active TSS Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
3	rs551575790	chr17:20799950-20799951	Weak transcription Strong transcription Genic enhancers Enhancers Active TSS Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
4	rs563574946	chr17:20799958-20799959	Weak transcription Strong transcription Genic enhancers Enhancers Active TSS Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
5	rs372817193	chr17:20799986-20799987	Weak transcription Strong transcription Genic enhancers Enhancers Active TSS Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
6	rs549314137	chr17:20799988-20799989	Weak transcription Strong transcription Genic enhancers Enhancers Active TSS Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
7	rs567857352	chr17:20799994-20799995	Weak transcription Strong transcription Genic enhancers Enhancers Active TSS Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
8	rs535444443	chr17:20800003-20800004	Weak transcription Strong transcription Genic enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
9	rs139598632	chr17:20800013-20800014	Weak transcription Strong transcription Genic enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
10	rs539191340	chr17:20800018-20800019	Weak transcription Strong transcription Genic enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
11	rs149257868	chr17:20800025-20800026	Weak transcription Strong transcription Genic enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
12	rs576348864	chr17:20800043-20800044	Weak transcription Strong transcription Genic enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
13	rs537233983	chr17:20800046-20800047	Weak transcription Strong transcription Genic enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
14	rs555708105	chr17:20800047-20800048	Weak transcription Strong transcription Genic enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
15	rs9898806	chr17:20800052-20800053	Weak transcription Strong transcription Genic enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
16	rs541437418	chr17:20800060-20800061	Weak transcription Strong transcription Genic enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
17	rs559454220	chr17:20800070-20800071	Weak transcription Strong transcription Genic enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
18	rs577956633	chr17:20800078-20800079	Weak transcription Strong transcription Genic enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
19	rs545126161	chr17:20800082-20800083	Weak transcription Strong transcription Genic enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
20	rs7502207	chr17:20800085-20800086	Weak transcription Strong transcription Genic enhancers	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs557313730	chr17:20800091-20800092	Weak transcription Strong transcription Genic enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
22	rs531053513	chr17:20800092-20800093	Weak transcription Strong transcription Genic enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
23	rs549128260	chr17:20800095-20800096	Weak transcription Strong transcription Genic enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
24	rs561631308	chr17:20800106-20800107	Weak transcription Strong transcription Genic enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
25	rs528753834	chr17:20800119-20800120	Weak transcription Strong transcription Genic enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
26	rs547254074	chr17:20800136-20800137	Weak transcription Strong transcription Genic enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
27	rs11204322	chr17:20800140-20800141	Weak transcription Strong transcription Genic enhancers	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs539434972	chr17:20800142-20800143	Weak transcription Strong transcription Genic enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
29	rs551538732	chr17:20800144-20800145	Weak transcription Strong transcription Genic enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
30	rs569726982	chr17:20800150-20800151	Weak transcription Strong transcription Genic enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
31	rs184488217	chr17:20800162-20800163	Weak transcription Strong transcription Genic enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
32	rs555571499	chr17:20800222-20800223	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs567565332	chr17:20800229-20800230	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs534646028	chr17:20800265-20800266	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs553212452	chr17:20800267-20800268	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs577994727	chr17:20800275-20800276	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs544992407	chr17:20800283-20800284	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs557048014	chr17:20800288-20800289	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs113221377	chr17:20800292-20800293	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs536748777	chr17:20800297-20800298	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs148774054	chr17:20800300-20800301	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs111983610	chr17:20800309-20800310	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs528662045	chr17:20800320-20800321	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs188935543	chr17:20800321-20800322	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs374392792	chr17:20800323-20800324	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs545553509	chr17:20800329-20800330	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs111446542	chr17:20800345-20800346	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs12950963	chr17:20800358-20800359	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs557536157	chr17:20800416-20800417	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs200980626	chr17:20800434-20800435	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:151)

Disease	PMID	Source
lymphocytic leukemia	21291569	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute promyelocytic leukemia	19109227	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Breast cancer	17603634	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
ovarian endometriomas	16273235	CNVD
Smith-Magenis syndrome	18923513	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Austim spectrum disorder	21302340	CNVD
Autism	22492990	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	18414209	CNVD
Developmental delay	21549014	CNVD
Epilepsy	20970697	CNVD
Mental retardation	18414209	CNVD
Mental retardation	21549014	CNVD
Smith-Magenis syndrome	21981782	CNVD
Smith-Magenis syndrome	20188345	CNVD
Smith-Magenis syndrome	16775514	CNVD
Smith-Magenis syndrome	22585170	CNVD
Smith-Magenis syndrome	22241247	CNVD
Autism	20970697	CNVD
Mental retardation	19951919	CNVD
Potocki-Lupski syndrome	21271655	CNVD
Potocki-lupski syndrome	17357070	CNVD
Potocki-lupski syndrome	20110824	CNVD
Potocki-lupski syndrome	18923514	CNVD
Potocki-lupski syndrome	22241247	CNVD
Potocki-lupski syndrome	20188345	CNVD
Schizophrenia	21399695	CNVD
Mental retardation	16773131	CNVD
Adenocarcinoma	19607727	CNVD
Squamous cell cancer	19607727	CNVD
Non-small cell lung cancer	21829676	CNVD
Glioblastoma multiforme	17002787	CNVD
Charcot-marie-tooth disease	22470819	CNVD
Neurofibromatosis	22470819	CNVD
Neuropathy	22470819	CNVD
Smith-Magenis syndrome	18301319	CNVD
Smith-Magenis syndrome	17357070	CNVD
Smith-Magenis syndrome	18469339	CNVD
Smith-Magenis syndrome	22241097	CNVD
Smith-Magenis syndrome	22470819	CNVD
Tourette syndrome	18923514	CNVD
Type 1 diabetes	22470819	CNVD
Potocki-lupski syndrome	18469339	CNVD
Follicular lymphoma	20505157	CNVD
T-cell lymphomas	19863542	CNVD
Neuropathy	17597781	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	17015230	CNVD
Smith-Magenis syndrome	17597781	CNVD
Potocki-lupski syndrome	18059269	CNVD
Potocki-lupski syndrome	17597781	CNVD
Mental retardation	17847001	CNVD
Multiple myeloma	16616336	CNVD
Breast cancer	20409316	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21509527	CNVD
Breast cancer	17142309	CNVD
Autism	20808228	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:62 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:20780800-20801600	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
2	chr17:20782600-20801200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
3	chr17:20789400-20801800	Weak transcription	iPS-18 Cell Line	embryonic stem cell
4	chr17:20798200-20801200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
5	chr17:20798200-20811600	Weak transcription	H9 Cell Line	embryonic stem cell
6	chr17:20798600-20801200	Weak transcription	HUES6 Cell Line	embryonic stem cell
7	chr17:20798800-20800200	Strong transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
8	chr17:20798800-20806800	Strong transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
9	chr17:20799000-20800000	Strong transcription	H1 Cell Line	embryonic stem cell
10	chr17:20799200-20800000	Active TSS	Fetal Brain Female	brain
11	chr17:20799200-20800200	Strong transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
12	chr17:20799400-20800000	Active TSS	Muscle Satellite Cultured Cells	--
13	chr17:20799600-20800000	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
14	chr17:20799600-20800000	Active TSS	Pancreas	Pancrea
15	chr17:20799600-20800200	Genic enhancers	ES-UCSF4 Cell Line	embryonic stem cell
16	chr17:20799800-20800000	Enhancers	Primary T helper naive cells fromperipheralblood	blood
17	chr17:20799800-20800000	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
18	chr17:20799800-20800200	Strong transcription	iPS DF 19.11 Cell Line	embryonic stem cell
19	chr17:20799800-20801600	Strong transcription	H9 Derived Neuron Cultured Cells	ES cell derived
20	chr17:20799800-20803400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
21	chr17:20800000-20802600	Weak transcription	H1 Cell Line	embryonic stem cell
22	chr17:20800200-20801200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
23	chr17:20800200-20801200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
24	chr17:20800200-20802800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
25	chr17:20800200-20811000	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
26	chr17:20801200-20801600	Enhancers	ES-I3 Cell Line	embryonic stem cell
27	chr17:20801200-20801600	Enhancers	HUES48 Cell Line	embryonic stem cell
28	chr17:20801200-20801600	Enhancers	HUES6 Cell Line	embryonic stem cell
29	chr17:20801200-20801800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
30	chr17:20801200-20801800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
31	chr17:20801200-20802000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
32	chr17:20801200-20803000	Enhancers	iPS-15b Cell Line	embryonic stem cell
33	chr17:20801200-20803200	Enhancers	HUES64 Cell Line	embryonic stem cell
34	chr17:20801600-20801800	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
35	chr17:20801600-20801800	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
36	chr17:20801600-20801800	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
37	chr17:20801600-20802200	Genic enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
38	chr17:20801600-20802200	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
39	chr17:20801600-20802400	Active TSS	iPS-20b Cell Line	embryonic stem cell
40	chr17:20801800-20802000	Active TSS	ES-I3 Cell Line	embryonic stem cell
41	chr17:20801800-20802200	Active TSS	iPS-18 Cell Line	embryonic stem cell
42	chr17:20801800-20802800	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
43	chr17:20801800-20803400	Enhancers	HUES48 Cell Line	embryonic stem cell
44	chr17:20801800-20812200	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
45	chr17:20802000-20802600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
46	chr17:20802000-20802800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
47	chr17:20802200-20802400	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
48	chr17:20802200-20803000	Enhancers	HUES6 Cell Line	embryonic stem cell
49	chr17:20802200-20807600	Strong transcription	H9 Derived Neuron Cultured Cells	ES cell derived
50	chr17:20802400-20802600	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links